vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Honest Company, Inc. (HNST). Click either name above to swap in a different company.
Honest Company, Inc. is the larger business by last-quarter revenue ($88.0M vs $85.1M, roughly 1.0× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -26.8%, a 49.6% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -11.8%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $18.1M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 1.0%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
The Honest Company, Inc. is an American digital-first consumer goods company, based in Los Angeles and founded by actress Jessica Alba, Christopher Gavigan, and Brian Lee. The company had $319 million in 2021 sales, and was valued at roughly $550 million as of February 2022. Carla Vernón, Chief Executive Officer, is one of the first Afro-Latina CEOs of a U.S. publicly traded company. The Honest Company has raised multiple rounds of venture capital, and went public via an initial public offeri...
FDMT vs HNST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $88.0M |
| Net Profit | $19.4M | $-23.6M |
| Gross Margin | — | 15.7% |
| Operating Margin | 17.3% | -27.5% |
| Net Margin | 22.8% | -26.8% |
| Revenue YoY | 8508900.0% | -11.8% |
| Net Profit YoY | 139.1% | -2813.2% |
| EPS (diluted) | $0.43 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $88.0M | ||
| Q3 25 | $90.0K | $92.6M | ||
| Q2 25 | $15.0K | $93.5M | ||
| Q1 25 | $14.0K | $97.3M | ||
| Q4 24 | $1.0K | $99.8M | ||
| Q3 24 | $3.0K | $99.2M | ||
| Q2 24 | $5.0K | $93.0M | ||
| Q1 24 | $28.0K | $86.2M |
| Q4 25 | $19.4M | $-23.6M | ||
| Q3 25 | $-56.9M | $758.0K | ||
| Q2 25 | $-54.7M | $3.9M | ||
| Q1 25 | $-48.0M | $3.3M | ||
| Q4 24 | — | $-809.0K | ||
| Q3 24 | $-43.8M | $165.0K | ||
| Q2 24 | $-35.0M | $-4.1M | ||
| Q1 24 | $-32.4M | $-1.4M |
| Q4 25 | — | 15.7% | ||
| Q3 25 | — | 37.3% | ||
| Q2 25 | — | 40.4% | ||
| Q1 25 | — | 38.7% | ||
| Q4 24 | — | 38.8% | ||
| Q3 24 | — | 38.7% | ||
| Q2 24 | — | 38.3% | ||
| Q1 24 | — | 37.0% |
| Q4 25 | 17.3% | -27.5% | ||
| Q3 25 | -67983.3% | 0.3% | ||
| Q2 25 | -396373.3% | 3.1% | ||
| Q1 25 | -383007.1% | 2.6% | ||
| Q4 24 | — | -1.0% | ||
| Q3 24 | -1704400.0% | 0.1% | ||
| Q2 24 | -849120.0% | -4.3% | ||
| Q1 24 | -136200.0% | -1.5% |
| Q4 25 | 22.8% | -26.8% | ||
| Q3 25 | -63195.6% | 0.8% | ||
| Q2 25 | -364386.7% | 4.1% | ||
| Q1 25 | -342657.1% | 3.3% | ||
| Q4 24 | — | -0.8% | ||
| Q3 24 | -1461433.3% | 0.2% | ||
| Q2 24 | -699060.0% | -4.4% | ||
| Q1 24 | -115717.9% | -1.6% |
| Q4 25 | $0.43 | $-0.21 | ||
| Q3 25 | $-1.01 | $0.01 | ||
| Q2 25 | $-0.98 | $0.03 | ||
| Q1 25 | $-0.86 | $0.03 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | $-0.79 | $0.00 | ||
| Q2 24 | $-0.63 | $-0.04 | ||
| Q1 24 | $-0.66 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $89.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $169.7M |
| Total Assets | $566.7M | $225.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $89.6M | ||
| Q3 25 | $305.1M | $71.5M | ||
| Q2 25 | $293.2M | $72.1M | ||
| Q1 25 | $321.4M | $72.8M | ||
| Q4 24 | $424.9M | $75.4M | ||
| Q3 24 | $501.9M | $53.4M | ||
| Q2 24 | $541.9M | $36.6M | ||
| Q1 24 | $525.9M | $33.6M |
| Q4 25 | $505.7M | $169.7M | ||
| Q3 25 | $369.0M | $190.2M | ||
| Q2 25 | $420.9M | $187.0M | ||
| Q1 25 | $469.7M | $180.4M | ||
| Q4 24 | $510.6M | $174.3M | ||
| Q3 24 | $552.9M | $133.9M | ||
| Q2 24 | $588.3M | $129.7M | ||
| Q1 24 | $600.6M | $124.8M |
| Q4 25 | $566.7M | $225.4M | ||
| Q3 25 | $424.0M | $241.5M | ||
| Q2 25 | $473.6M | $249.0M | ||
| Q1 25 | $515.7M | $265.3M | ||
| Q4 24 | $560.4M | $247.4M | ||
| Q3 24 | $604.0M | $209.2M | ||
| Q2 24 | $620.1M | $200.2M | ||
| Q1 24 | $629.9M | $198.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $19.3M |
| Free Cash FlowOCF − Capex | $28.5M | $18.1M |
| FCF MarginFCF / Revenue | 33.5% | 20.5% |
| Capex IntensityCapex / Revenue | 0.1% | 1.4% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $19.3M | ||
| Q3 25 | $-46.5M | $-504.0K | ||
| Q2 25 | $-43.4M | $-745.0K | ||
| Q1 25 | $-47.8M | $-2.9M | ||
| Q4 24 | $-134.6M | $-16.8M | ||
| Q3 24 | $-29.4M | $15.1M | ||
| Q2 24 | $-30.2M | $2.9M | ||
| Q1 24 | $-29.1M | $336.0K |
| Q4 25 | $28.5M | $18.1M | ||
| Q3 25 | $-46.6M | $-624.0K | ||
| Q2 25 | $-43.4M | $-826.0K | ||
| Q1 25 | $-48.4M | $-3.0M | ||
| Q4 24 | $-138.4M | $-17.2M | ||
| Q3 24 | $-31.2M | $15.0M | ||
| Q2 24 | $-30.6M | $2.9M | ||
| Q1 24 | $-29.8M | $260.0K |
| Q4 25 | 33.5% | 20.5% | ||
| Q3 25 | -51765.6% | -0.7% | ||
| Q2 25 | -289620.0% | -0.9% | ||
| Q1 25 | -345635.7% | -3.1% | ||
| Q4 24 | -13837100.0% | -17.2% | ||
| Q3 24 | -1038966.7% | 15.1% | ||
| Q2 24 | -611840.0% | 3.1% | ||
| Q1 24 | -106421.4% | 0.3% |
| Q4 25 | 0.1% | 1.4% | ||
| Q3 25 | 101.1% | 0.1% | ||
| Q2 25 | 440.0% | 0.1% | ||
| Q1 25 | 4507.1% | 0.1% | ||
| Q4 24 | 378600.0% | 0.3% | ||
| Q3 24 | 59266.7% | 0.1% | ||
| Q2 24 | 6980.0% | 0.0% | ||
| Q1 24 | 2535.7% | 0.1% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | — | -0.19× | ||
| Q1 25 | — | -0.90× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 91.42× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
